SCHEMBL22013894

SCHEMBL22013894

CO[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@H]4CC[C@@H]([C@@H](C)CCCC(C)C)[C@@]4(C)CC[C@H]32)C1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP46A1 Q9Y6A2 2/20 0.77
POLA1 P09884 1/20 0.76
OSBP P22059 4/20 0.75
RORC P51449 3/20 0.75
USP2 O75604 2/20 0.75
OSBP2 Q969R2 2/20 0.75
LMNA P02545 1/20 0.75
ABCB1 P08183 1/20 0.75
ACHE P22303 1/20 0.69
EBP Q15125 1/20 0.69
DHCR7 Q9UBM7 1/20 0.69
GRIN1 Q05586 2/20 0.64
GRIN2A Q12879 2/20 0.64
NR1H3 Q13133 3/20 0.64
GBA1 P04062 2/20 0.63
UGCG Q16739 2/20 0.63
GBA2 Q9HCG7 2/20 0.63
NPC1L1 Q9UHC9 3/20 0.61
CRYAB P02511 1/20 0.61
HMGCR P04035 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20459397 1.00 CYP46A1 (0.77) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL4738486 1.00 CYP46A1 (0.77) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL15150903 1.00 CYP46A1 (0.77) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL17663640 1.00 CYP46A1 (0.77) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL12940685 1.00 CYP46A1 (0.77) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL24405093 1.00 CYP46A1 (0.77) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL20924867 1.00 CYP46A1 (0.77) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL22389093 1.00 CYP46A1 (0.77) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL21707464 1.00 CYP46A1 (0.77) CYP46A1POLA1OSBPRORCUSP2
SCHEMBL12896265 1.00 CYP46A1 (0.77) CYP46A1POLA1OSBPRORCUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10660969-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2020-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10660969-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof MRPL38, ALG8, COG8 CYP46A1 796/4885POLA1 1009/4885OSBP 2585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.